Skip to main content
HCAT
NASDAQ Technology

Health Catalyst Posts $40.5M Q3 Net Income

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.5
Mkt Cap
$112.885M
52W Low
$0.955
52W High
$3.36
52W Position info
57% above low
Off High info
55% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

HCAT sits 57% above its 52-week low of $0.955.

Summary

Health Catalyst reported $40.5 million of third-quarter net income, or 53 cents a share, a swing to profit for a company that posted a $151.6 million net loss in Q2 2026, which included a $122.5 million goodwill impairment. Third-quarter revenue was $56.3 million, and the results came in above guidance, with the company reaffirming its 2026 outlook. Adjusted EBITDA declined sharply on the Vitalware divestiture. The result lands as new CEO Simeon Kohl, in the seat since September 14, works under pressure from activist Palogic Value Management, which holds 7.1% and has demanded a clear business plan. A profitable quarter is the strongest answer management could give to that critique.

At the time of this announcement, HCAT was trading at $1.50 on NASDAQ in the Technology sector, with a market capitalization of approximately $112.9M. The 52-week trading range was $0.96 to $3.36. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

HCAT - Latest Insights

HCAT
Nov 05, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.31 info
Change: -$0.390 (-23%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.31 info
Change: -$0.320 (-20%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.31 info
Change: -$0.360 (-22%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:03 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.86
Real-time Price: $1.31 info
Change: -$0.550 (-30%) info
Market Cap: $99.764M info